Apogee Therapeutics, Inc. (APGE) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 1.07B | 741.36M | 540.1M | 516.12M | 521.53M | 529.71M | 534.48M | 681.85M | 820.61M | 398.41M | 426.42M | 130.67M |
| Cash & Short-Term Investments | 1.06B | 730.19M | 527.29M | 505.42M | 513.33M | 520.65M | 526.05M | 676.23M | 816.2M | 395.46M | 422.85M | 125.07M |
| Cash Only | 451.8M | 131.55M | 107.91M | 124.19M | 106.92M | 141.79M | 118.78M | 307.3M | 485.46M | 118.32M | 188.27M | 125.07M |
| Short-Term Investments | 608.09M | 598.64M | 419.38M | 381.23M | 406.41M | 378.86M | 407.27M | 368.93M | 330.74M | 277.14M | 234.59M | 0 |
| Accounts Receivable | 0 | 0 | 4.48M | 4.14M | 5.01M | 4.7M | 4.77M | 0 | 0 | 1.21M | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 13.91M | 11.17M | 919K | 963K | 586K | 1.74M | 396K | 3.39M | 2.72M | 0 | 1.41M | 4.36M |
| Total Non-Current Assets | 219.86M | 195.78M | 86.06M | 141.65M | 192.63M | 224.24M | 241.8M | 118.8M | 3.05M | 3M | 200K | 0 |
| Property, Plant & Equipment | 12.99M | 14.38M | 15.68M | 17.02M | 17.19M | 13.32M | 13.54M | 4.94M | 2.65M | 2.59M | 0 | 0 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 61.64M | 115.77M | 168.11M | 210.42M | 227.75M | 113.39M | 294K | 300K | 0 | 0 |
| Other Non-Current Assets | 206.87M | 181.4M | 8.74M | 8.86M | 7.34M | 498K | 514K | 468K | 107K | 101K | 200K | 0 |
| Total Assets | 1.29B | 937.13M | 626.16M | 657.77M | 714.16M | 753.95M | 776.29M | 800.66M | 823.66M | 401.4M | 426.42M | 130.67M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 81.14% | 24.3% | -19.34% | -17.85% | -13.29% | 87.83% | 82.05% | 512.75% | 479.97% | 163.99% | - | - |
| Total Current Liabilities | 32.95M | 27.91M | 34.05M | 31.55M | 32.96M | 28.56M | 32.61M | 24.62M | 21.55M | 20.56M | 17.18M | 17.61M |
| Accounts Payable | 1.24M | 1.22M | 376K | 5.68M | 2.44M | 1.07M | 2.22M | 5.53M | 4.3M | 2.14M | 1.21M | 11.15M |
| Days Payables Outstanding | 271.1 | -183.66 | 696.21 | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 3.14M | 3.5M | 0 | 4.03M | 3.98M | 3.23M | 2.87M | 1.68M | 1.14M | 1.1M | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 28.58M | 23.18M | 12.68M | 13.69M | 21.32M | 22.36M | 20.61M | 13.35M | 13.82M | 17.15M | 13.75M | 885K |
| Current Ratio | 32.59x | 26.57x | 15.86x | 16.36x | 15.82x | 18.55x | 16.39x | 27.70x | 38.08x | 19.38x | 24.82x | 7.42x |
| Quick Ratio | 32.59x | 26.57x | 15.86x | 16.36x | 15.82x | 18.55x | 16.39x | 27.70x | 38.08x | 19.38x | 24.82x | 7.42x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.91M | 5.34M | 5.77M | 6.82M | 7.84M | 8.6M | 9.27M | 2.4M | 630K | 933K | 0 | 0 |
| Long-Term Debt | 4.91M | 5.34M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 5.77M | 6.82M | 7.84M | 8.6M | 9.27M | 2.4M | 630K | 933K | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 37.86M | 33.25M | 39.82M | 38.37M | 40.8M | 37.16M | 41.88M | 27.02M | 22.18M | 21.49M | 17.18M | 17.61M |
| Total Debt | 8.05M | 8.85M | 9.85M | 10.85M | 11.82M | 11.83M | 12.14M | 4.08M | 1.77M | 2.03M | 0 | 0 |
| Net Debt | -443.75M | -122.7M | -98.06M | -113.35M | -95.1M | -129.96M | -106.64M | -303.22M | -483.69M | -116.28M | -188.27M | -125.07M |
| Debt / Equity | 0.01x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x | 0.01x | 0.00x | 0.01x | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Equity | 1.26B | 903.88M | 586.34M | 619.4M | 673.36M | 716.79M | 734.4M | 773.64M | 801.48M | 379.91M | 409.24M | 113.05M |
| Equity Growth % | 86.5% | 26.1% | -20.16% | -19.94% | -15.98% | 88.67% | 79.45% | 584.32% | 512.64% | 167.4% | - | - |
| Book Value per Share | 18.03 | 14.89 | 9.98 | 10.60 | 11.57 | 12.99 | 12.93 | 13.69 | 15.97 | 7.50 | 8.08 | 2.23 |
| Total Shareholders' Equity | 1.26B | 903.88M | 586.34M | 619.4M | 673.36M | 716.79M | 734.4M | 773.64M | 801.48M | 379.91M | 409.24M | 113.05M |
| Common Stock | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 1K | 0 | 0 | 6.78M |
| Retained Earnings | -635.87M | -561.76M | -492.37M | -427.35M | -361.25M | -305.92M | -238.7M | -189.68M | -155.86M | -123.77M | -92.03M | -71.19M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -749K | 1.08M | 1.03M | 685K | 1.07M | 915K | 3.27M | -289K | -177K | 329K | 135K | 4.53M |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |